Junto Capital Management’s Zimmer Biomet ZBH Stock Holding History

Junto Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-505,936	Closed	-$73.7M	–	95
2023 Q2	$73.7M	Buy	505,936 +35,455	+8%	+$4.82M	1.87%	20
2023 Q1	$60.8M	Buy	470,481 +181,074	+63%	+$22.7M	1.68%	17
2022 Q4	$36.9M	Buy	+289,407	New	+$33.6M	1.05%	44

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Junto Capital Management's ZBH Position: Q3 2023 in Review

Junto Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 505,936 shares — an estimated $73.7M sold.

Junto Capital Management first reported a position in ZBH in Q4 2022 and held it in 3 quarters. The position peaked at $73.7M in Q2 2023. 1,015 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

Junto Capital Management reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
Junto Capital Management sold 505,936 Zimmer Biomet shares in Q3 2023, an estimated $73.7M.
Junto Capital Management first reported a position in Zimmer Biomet in Q4 2022 and held it in 3 quarters.
Junto Capital Management's Zimmer Biomet position peaked at $73.7M in Q2 2023.
1,015 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Junto Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.